Fentanyl, a potent synthetic opioid, has garnered attention for its devastating role in the opioid epidemic. Initially developed for pain management, particularly in cancer patients, fentanyl is 50 to 100 times more potent than morphine (Schifano et al., 2019). While its physical effects, including respiratory depression and overdose risk, are well-documented, the mental health consequences of fentanyl use and misuse are equally severe but less frequently discussed. This article explores the psychological impact of fentanyl, focusing on how its use can exacerbate or trigger mental health disorders.

Keywords: Fentanyl addiction treatment, Reversing fentanyl addiction, Medication-assisted treatment for fentanyl, Fentanyl withdrawal management, Opioid addiction recovery, Fentanyl overdose treatment, Long-term recovery from fentanyl

Long-term opioid use, including fentanyl, is strongly associated with the onset and worsening of depressive disorders. Fentanyl’s powerful euphoric effects can lead to a cycle of emotional dependence, as users rely on the drug to manage emotional pain, leading to a blunted ability to experience pleasure or normal emotions when not using (Volkow et al., 2018). This phenomenon, known as opioid-induced anhedonia, can significantly increase the risk of developing major depressive episodes.

Individuals who misuse fentanyl may also experience mood swings, irritability, and feelings of worthlessness or guilt, further contributing to the cycle of addiction and depression (Schifano et al., 2019). The comorbid nature of substance abuse and depression makes treatment particularly challenging, as both conditions often need to be addressed simultaneously.

Anxiety disorders are another common mental health issue exacerbated by fentanyl use. Many individuals use opioids to self-medicate for anxiety, but over time, fentanyl can heighten feelings of restlessness, panic, and paranoia. Prolonged use often leads to changes in brain chemistry that make it more difficult for the individual to manage stress without the drug, creating a dependency cycle.

The withdrawal symptoms associated with fentanyl, which can include severe anxiety, agitation, and panic attacks, contribute to the difficulty of overcoming addiction. For some users, the fear of experiencing withdrawal can perpetuate ongoing use, even when they want to quit (Kosten & George, 2002).

Fentanyl use, particularly when mixed with other substances or taken in large amounts, has been linked to episodes of psychosis and hallucinations. Some users report seeing or hearing things that aren’t there, feeling detached from reality, or experiencing delusions. While these symptoms are more commonly associated with stimulant use, the powerful nature of fentanyl and its effects on the brain’s reward and pleasure centres can lead to similar experiences (Rudd et al., 2016).

Opioid-induced psychosis is particularly dangerous because it can impair judgment and increase the likelihood of risky behaviour, such as further substance abuse or self-harm.

Chronic fentanyl use can result in cognitive deficits, including problems with memory, attention, and decision-making. Opioids affect the brain’s prefrontal cortex, which is responsible for executive functioning, leading to impaired impulse control and increased risk-taking behaviours (Schifano et al., 2019).

Over time, individuals using fentanyl may struggle to complete everyday tasks or make sound decisions, further compounding the social and personal consequences of addiction. Cognitive impairment also poses a significant barrier to treatment, as it makes it harder for individuals to engage in psychotherapy or rehabilitation programs.

The opioid epidemic has been linked to an increase in suicide rates, particularly among individuals with opioid use disorder (OUD). Fentanyl’s depressive effects on the central nervous system, combined with its tendency to exacerbate pre-existing mental health issues, can increase feelings of hopelessness and despair. Research has shown that individuals with OUD are at a significantly higher risk of suicidal ideation and suicide attempts, especially if they also suffer from untreated depression or anxiety (Pfefferbaum et al., 2020).

Fentanyl’s role in suicide is not limited to overdose deaths, as many suicides among opioid users are intentional, driven by overwhelming feelings of hopelessness and emotional pain.

Fentanyl use often co-occurs with other substance use disorders, such as alcohol or benzodiazepine abuse, further complicating mental health outcomes. Co-occurring disorders (often referred to as dual diagnoses) present unique challenges in treatment, as individuals may experience a worsening of both substance use and mental health symptoms when only one condition is addressed.

For example, individuals with bipolar disorder or schizophrenia who use fentanyl may experience more frequent mood swings, psychotic episodes, and suicidal thoughts, making it difficult to stabilise either condition without comprehensive treatment (Volkow et al., 2018).

Fentanyl is one of the most potent opioids available and stands out in comparison to other opioids due to its extreme potency, rapid onset, and significant risk for misuse and overdose. Here’s a detailed comparison of fentanyl with other commonly used opioids such as morphine, heroin, and oxycodone:

Fentanyl is 50 to 100 times more potent than morphine and approximately 50 times more potent than heroin (Stanley, 2014). This means that very small doses of fentanyl can produce effects similar to much larger doses of other opioids. Its high potency is both a reason for its medical use in managing severe pain and a major contributor to its risk of overdose when misused.

• Morphine: Often considered the gold standard for opioid pain relief, morphine is much less potent than fentanyl. It is commonly used in both acute and chronic pain settings but is far less likely to cause overdose in such small amounts compared to fentanyl.
• Heroin: Heroin is an illicit opioid that is chemically similar to morphine. While it is potent, fentanyl is much stronger, which has led to a surge in overdose deaths when fentanyl is laced with or substituted for heroin.
• Oxycodone: A widely prescribed opioid, oxycodone is also less potent than fentanyl. Oxycodone’s oral forms are common for treating moderate to severe pain, but it carries a lower risk of overdose than fentanyl due to its lower potency.

Fentanyl is fast-acting, with an onset of action that can occur within minutes when delivered through intravenous, transdermal, or buccal routes. Its rapid onset makes it particularly useful for managing severe acute pain, such as in surgical settings or in cancer patients. However, the fast onset also increases the risk of respiratory depression and overdose when misused (Volkow et al., 2014).

• Morphine: Morphine typically has a slower onset, especially when taken orally, which can range from 30 minutes to an hour. It has a longer duration of action compared to fentanyl, lasting 3-4 hours for immediate-release forms.
• Heroin: Heroin’s onset of action is typically faster than morphine when injected, but still slower compared to fentanyl. The effects last around 3-6 hours, depending on the method of use.
• Oxycodone: Immediate-release forms of oxycodone have an onset of action within 10-30 minutes, and the effects can last for 3-6 hours. Extended-release forms can provide relief for up to 12 hours but are still much slower compared to fentanyl.

Fentanyl’s potency and rapid action increase the risk of accidental overdose, particularly in individuals who are unaware they are consuming fentanyl-laced drugs. Even a microgram-level dose can cause respiratory depression and death. The risk is exacerbated when fentanyl is mixed with other opioids, benzodiazepines, or alcohol (Schifano et al., 2019).

• Morphine: While overdose is still a risk with morphine, it generally requires higher doses to reach dangerous levels compared to fentanyl. It is more predictable in clinical use due to its slower onset and lower potency.
• Heroin: Heroin is also associated with high overdose risk, but when mixed with fentanyl (which is common in illicit drug markets), the risk increases dramatically.
• Oxycodone: Like morphine, oxycodone carries a risk of overdose, particularly with extended misuse or when taken with other depressants. However, fentanyl presents a much greater immediate overdose risk, even in small doses.

Fentanyl is frequently used in clinical settings for managing severe pain, particularly for post-operative and cancer pain. It is often delivered via transdermal patches or lozenges for long-term pain management in cancer patients, or intravenously in acute medical settings.

• Morphine is also used in hospitals for moderate to severe pain, particularly in post-surgical and palliative care, but has broader general use due to its predictability and lower risk profile.
• Heroin has no accepted medical use in most countries, although it is used in some places like the UK under the name diamorphine for pain management.
• Oxycodone is commonly prescribed for a range of pain conditions, particularly for chronic pain, and is available in both immediate and extended-release forms.

Fentanyl’s availability on the black market and its widespread mixing with other drugs like heroin and counterfeit pills has contributed to a significant increase in overdose deaths worldwide. Due to its extreme potency, illicit fentanyl can be fatal even in small amounts, especially when users are unaware they are consuming it (Rudd et al., 2016).

• Morphine: While still subject to abuse, morphine is less common in illicit markets compared to heroin or fentanyl.
• Heroin: One of the most widely abused illicit opioids, heroin’s lethality has increased with the rise of fentanyl-laced batches, making it more dangerous for users.
• Oxycodone: Oxycodone has been heavily abused, particularly in the U.S., leading to strict regulations in its prescription. However, it remains a major part of the opioid crisis, though it is far less lethal compared to fentanyl.

Fentanyl withdrawal has profound effects on the brain, primarily because it disrupts the brain’s normal functioning by acting on its opioid receptors. Fentanyl binds to these receptors, creating powerful feelings of euphoria and pain relief. However, prolonged use can lead to significant neurological changes that manifest during withdrawal. Here’s how fentanyl withdrawal affects the brain:

Fentanyl significantly alters the brain’s reward system by overstimulating dopamine pathways. During use, fentanyl causes a surge of dopamine, reinforcing drug-taking behaviours. Over time, the brain becomes dependent on the drug to release dopamine, leading to a blunted reward response for natural pleasures such as food or social interaction (Volkow et al., 2018). During withdrawal, the lack of dopamine causes anhedonia (inability to feel pleasure), which can persist for weeks or months.

The hypothalamic-pituitary-adrenal (HPA) axis, which regulates stress, becomes dysregulated in individuals dependent on opioids like fentanyl. When someone stops using the drug, they may experience hyperactivity of the HPA axis, leading to heightened stress responses, anxiety, and emotional instability (Kosten & George, 2002). This is why many individuals going through fentanyl withdrawal experience severe anxiety, restlessness, and agitation.

Opioids like fentanyl not only relieve pain but can also increase pain sensitivity over time—a condition known as opioid-induced hyperalgesia. During withdrawal, the brain’s ability to regulate pain becomes impaired, causing increased sensitivity to pain even in the absence of external stimuli (Compton et al., 2001). This heightened pain sensitivity is one of the reasons why withdrawal is so physically uncomfortable.

Fentanyl use causes significant changes in the prefrontal cortex, the area of the brain responsible for decision-making, impulse control, and emotional regulation. During withdrawal, this region of the brain is less effective, leading to strong cravings and difficulty in resisting the urge to use the drug again (Schifano et al., 2019). The brain’s executive function is impaired, making it challenging for individuals to regulate their behaviour during withdrawal.

Withdrawal from fentanyl often results in intense psychological symptoms, including depression, anxiety, and mood swings. These symptoms occur because the brain’s neurotransmitter systems, particularly those involving serotonin and norepinephrine, are disrupted. The brain, accustomed to the drug’s mood-altering effects, struggles to regulate emotions without the presence of fentanyl (Kosten & George, 2002). The return to normal neurotransmitter function is slow, contributing to prolonged emotional distress.

The autonomic nervous system (ANS), which controls involuntary functions such as heart rate, blood pressure, and digestion, is also affected during fentanyl withdrawal. Symptoms like sweating, nausea, vomiting, and shaking occur as the brain attempts to rebalance its control over the ANS (Kosten & George, 2002). This dysregulation leads to the intense physical symptoms associated with opioid withdrawal.

Chronic fentanyl use can cause lasting cognitive impairments, including memory problems, <strong class=”x-el x-e